Ronald Cobb - BWV Head Discovery
Ronald Cobb is Portfolio Manager at BWV
| Phone | 513 620 4101 |
| Web | https://www.bluewatervaccines.com |
BWV Management Efficiency
The company has Return on Asset of (0.3022) % which means that on every $100 spent on assets, it lost $0.3022. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.0163) %, meaning that it generated no profit with money invested by stockholders. BWV's management efficiency ratios could be used to measure how well BWV manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Sharon McBrayer | Palisade Bio | N/A | |
| Cameron Shaw | Virax Biolabs Group | 37 | |
| Steen Knudsen | Allarity Therapeutics | 64 | |
| James Rolke | Revelation Biosciences | 56 | |
| Tomasz George | Virax Biolabs Group | 40 | |
| MD DrSc | Allarity Therapeutics | 81 | |
| Meeshanthini Dogan | Cardio Diagnostics Holdings | 36 | |
| Brian Strem | Kiora Pharmaceuticals | 46 | |
| MD FAAAAI | Palisade Bio | N/A | |
| James Foster | Virax Biolabs Group | 40 | |
| MPA MD | Unicycive Therapeutics | 52 | |
| Carol Odle | Revelation Biosciences | N/A | |
| Robert McRae | Palisade Bio | N/A | |
| Chester III | Revelation Biosciences | 45 | |
| James JD | Allarity Therapeutics | 55 | |
| Jason Davis | Virax Biolabs Group | 53 | |
| Professor MD | Allarity Therapeutics | 67 | |
| Claus Pedersen | Allarity Therapeutics | 52 | |
| John CPA | Unicycive Therapeutics | 63 | |
| MaryJane Rafii | Kiora Pharmaceuticals | N/A | |
| MD MBA | Kiora Pharmaceuticals | 52 | |
Management Performance
| Return On Equity | -1.02 | |||
| Return On Asset | -0.3 |
BWV Money Managers
| Theodore Yoho, Head Devel | ||
| Erin Henderson, Chief Sec | ||
| Brian Price, Head Strategy | ||
| Andrew Skibo, Global Operations | ||
| Jon Garfield, Chief Officer | ||
| MBA MS, Pres CEO | ||
| Ronald Cobb, Head Discovery |
BWV Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BWV a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.02 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 8.81 M | |||
| Shares Outstanding | 18.66 M | |||
| Shares Owned By Insiders | 17.69 % | |||
| Shares Owned By Institutions | 23.44 % | |||
| Number Of Shares Shorted | 23.33 K | |||
| Price To Book | 0.35 X | |||
| EBITDA | (13.54 M) | |||
| Net Income | (13.42 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Tools for BWV Etf
When running BWV's price analysis, check to measure BWV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BWV is operating at the current time. Most of BWV's value examination focuses on studying past and present price action to predict the probability of BWV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BWV's price. Additionally, you may evaluate how the addition of BWV to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |